This website is intended for healthcare professionals

News Analysis

Corticosteroids for reducing mortality and mechanical ventilation

The study involved a selection of randomised clinical trials in which people with suspected, probable or confirmed COVID-19 were allocated at random to drug treatment, standard care, or placebo. Pairs...

How world policy affects the equitable distribution of the COVID-19 vaccine

In a study recently published in the British Medical Journal, So and Woo (2020) analysed the premarket purchase commitments for COVID-19 vaccines from leading manufacturers to recipient countries.

Treating and preventing COVID-19: how close are we?

The antibody drug, Regeneron, was partially credited for successfully treating outgoing American President Donald Trump. It has now received emergency approval in the US for use in people who have...

Novel application of ozone therapy for current and emerging diseases

In 1929, a book entitled ‘Ozone and its therapeutic actions’ was published, detailing more than 100 diseases that could be treated by O3 therapy (Juchniewicz and Lubkowska, 2020), and our knowledge of...

Racial disparity and implicit bias in prescribing practice

Donna Kinnair, head of the Royal College of Nursing (herself no stranger to racism as a black woman living in the UK) points out that patients in black and minority communities have the worst outcomes...

Cardiac effects of cancer therapy and what is being done about it

The drug doxorubicin slows or stops the spread of cancer cells by blocking the enzyme, topoisomerase, which cancer cells rely on for their division and growth (Cancer Research UK (CRUK), 2019). It is...

Long-term effects of COVID-19: impact on prescribing practice

This article provides follow-up guidance on patients with the most severe COVID-19 disease, namely, those that required critical care or had changes noted on chest x-ray consistent with COVID-19...

Reframing the way we think about cancer therapy

One such therapy, first offered to patients in the UK in early 2019, is chimeric antigen receptor T-cell (CAR-T). CAR-T forms part of a newer class of medicines called advanced therapy medicinal...

Changing the way pain is perceived

Millions of patients across Britain, as well as their families and carers, are affected by chronic pain. Unfortunately, chronic pain can have a devastating impact upon a person's day-to-day life,...

Opioid prescribing raises concerns

There appear to be high rates of hospital admissions for drug misuse poisoning in areas with high levels of opioid prescription (Burns, 2019). Although local authority spokespeople claim there is no...

Dependence and withdrawal: how to better support patients

The PHE (2019) review was a response to a call from the Minister for public health and primary care in 2017 for PHE to identify the scale, distribution and causes of prescription drug dependence, and...

Action in asthma: the basics and beyond

The basic care in the UK referred to by Asthma UK consists of the prescription and use of preventer, reliever and combination inhalers, as well as tablets, injections, surgery and other novel...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP